Intratumoral IL-18 gene transfer improves therapeutic efficacy of antibody-targeted superantigen in established murine melanoma.

Antibody-targeted superantigen C215Fab-SEA is a fusion protein of staphylococcal enterotoxin A (SEA) and the Fab region of the tumor-reactive C215 mAb. It can trigger CTL against C215 antigen-positive tumor cells and induce tumor-suppressive cytokines. However, the antitumor effect of C215Fab-SEA is not satisfactory because of suboptimal production of Th1 cytokines after repeated administration. Interleukin 18 (IL-18) is a novel cytokine with profound effects on Th1 cellular response. In this study, we showed that adenovirus-mediated intratumoral IL-18 gene transfer strongly improved the therapeutic efficacy of C215Fab-SEA in the pre-established C215 antigen-expressing B16 melanoma murine model. More significant tumor inhibition and prolonged survival time were observed in tumor-bearing mice received combined therapy of C215Fab-SEA and Ad IL-18 than those of mice treated with C215Fab-SEA or AdIL-18 alone. Combination therapy augmented NK and CTL activities of tumor-bearing mice more markedly. The production of IL-2 and IFN-gamma also increased more significantly. More potent antitumor effect of combined therapy was observed in IL-10 KO mice with enhanced Th1 response. Our data demonstrated that the antitumor effect of C215Fab-SEA immunotherapy could be potentiated significantly by combination with intratumoral IL-18 gene transfer through more efficient activation of Th1 immune responses.
AuthorsQ Wang, H Yu, D W Ju, L He, J P Pan, D J Xia, L H Zhang, X Cao
JournalGene therapy (Gene Ther) Vol. 8 Issue 7 Pg. 542-50 (Apr 2001) ISSN: 0969-7128 [Print] England
PMID11319621 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Neoplasm
  • Cytokines
  • Enterotoxins
  • Immunoglobulin Fab Fragments
  • Interleukin-18
  • Recombinant Fusion Proteins
  • Superantigens
  • enterotoxin A, Staphylococcal
  • Adenoviridae (genetics)
  • Animals
  • Antigens, Neoplasm (immunology)
  • Combined Modality Therapy
  • Cytokines (biosynthesis)
  • Cytotoxicity, Immunologic
  • Enterotoxins (immunology)
  • Female
  • Genetic Therapy (methods)
  • Immunoglobulin Fab Fragments (immunology)
  • Interleukin-18 (genetics, immunology)
  • Killer Cells, Natural (immunology)
  • Male
  • Melanoma, Experimental (immunology, pathology, therapy)
  • Mice
  • Mice, Inbred C57BL
  • Recombinant Fusion Proteins (therapeutic use)
  • Spleen (immunology)
  • Staphylococcus aureus (immunology)
  • Superantigens (immunology, therapeutic use)
  • Survival Rate
  • T-Lymphocytes, Cytotoxic (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: